← SynDRA
MITOFLAXONE
SynDRA canonical compound SYN0003088 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | VWF |
|---|
| Mechanism of action | antitumor agent |
|---|
All known targets
Mechanisms of action (all sources)
- antitumor agent
- VWF INHIBITOR
Drug classes
- Adjuvants, Immunologic
- Antineoplastic Agents
Cross-references
Synonyms
- Mitoflaxona
- NSC-347512
- Flavone acetic acid
- Flavone-8- acetic acid
- LM 975
- NSC 347512
- Mitoflaxone [INN]
- Mitoflaxonum [INN-Latin]
- Mitoflaxona [INN-Spanish]
- 4H-1-BENZOPYRAN-8-ACETIC ACID, 4-OXO-2-PHENYL-
- UNII-X230G6E63B
- 2-Phenyl-8-(carboxymethyl)-benzopyran-4-one
- NSC347512
- 4-Oxo-2-phenyl-4H-1-benzopyran-8-acetic acid
- BRN 4260339
- MLS003171055
- TZZNWMJZDWYJAZ-UHFFFAOYSA-N
- X230G6E63B
- Mitoflaxonum
- C17H12O4
- Flavoneacetic acid
- AC1L1JPE
- NCIStruc2_000951
- FAA, Merck
- Flavone acetic acid, Merck
- Flavone-8-Acetic Acid
- LM-975
- 4H-1-benzopyran-8-acetic Acid, 4-Oxo-2-phenyl
- RefChem:159087
- DTXCID80159025
- (4-Oxo-2-phenyl-4H-chromen-8-yl)-acetic acid
- 2-(4-oxo-2-phenylchromen-8-yl)acetic acid
- (4-Oxo-2-phenyl-4H-chromen-8-yl)acetic acid
- 2-(4-oxo-2-phenyl-4H-chromen-8-yl)acetic acid
- Mitoflaxone [WHO-DD]
- NCIStruc1_000708
- SCHEMBL106705
- CCG-36701
- CRC-85/31
Look up MITOFLAXONE in the interactive SynDRA portal →